Could a weekly shot help people with type 1 diabetes control blood sugar better?

NCT ID NCT06630585

First seen Jan 06, 2026 · Last updated May 12, 2026 · Updated 20 times

Summary

This study is for adults with type 1 diabetes who already use an automated insulin delivery system. Researchers want to see if adding a weekly injection of tirzepatide (a drug that helps control blood sugar and weight) can improve glucose levels even more. About 42 people will take part, and the study will compare time in the target blood sugar range between those who get the drug and those who don't.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES (T1D) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • DiaCenTRE - Hirslanden Clinique des Grangettes

    RECRUITING

    Chêne-Bougeries, Canton of Geneva, 1224, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Kantonsspital Olten

    RECRUITING

    Olten, Canton of Solothurn, 4600, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Luzerner Kantonspital

    RECRUITING

    Lucerne, 6000, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.